Patent · US Active

13-transmembrane protein expressed in prostate cancer

US8383777B2 · kind B2 · utility

1Cited by

22References

8Claims

0Family size

Assignee

Latency, LLC · US

Inventors

Daniel Afar · Santa Monica, US
Rene S. Hubert · Los Angeles, US
Kahan Leong · El Segundo, US
Arthur B. Raitano · Los Angeles, US
Douglas Saffran · Los Angeles, US

Key dates

Filing date	Aug 20, 2007
Grant date	Feb 26, 2013
Priority date	—
Expiry date	Mar 18, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2799/027
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A novel prostate tumor associated gene (designated 24P4C12) and its encoded protein is described. 24P4C12 is highly expressed in prostate tissue xenografts, providing evidence that it is turned on in at least some prostate cancers. 24P4C12 provides a diagnostic and/or therapeutic target for prostate and other cancers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.